(Q37013907)

17 August 2017

1 reference

title

Guidelines on iron chelation therapy in patients with myelodysplastic syndromes and transfusional iron overload (English)

1 reference

17 August 2017

0 references

0 references

0 references

1

Norbert Gattermann

1 reference

PubMed ID

18037413

17 August 2017

language of work or name

1 reference

1 December 2007

1 reference

17 August 2017

1 reference

17 August 2017

31 Suppl 3

1 reference

17 August 2017

S10-5

1 reference

Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major

17 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2807%2970461-7

7 January 2021

Iron overload and myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2807%2970461-7

7 January 2021

Guidelines for the diagnosis and therapy of adult myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2807%2970461-7

7 January 2021

Frequent severe liver iron overload after stem cell transplantation and its possible association with invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2807%2970461-7

7 January 2021

Rust and corrosion in hematopoietic stem cell transplantation: the problem of iron and oxidative stress

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2807%2970461-7

7 January 2021

Iron overload is a major risk factor for severe infection after autologous stem cell transplantation: a study of 367 myeloma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2807%2970461-7

7 January 2021

Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2807%2970461-7

7 January 2021

Early clinical impact of iron overload in stem cell transplantation. A prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2807%2970461-7

7 January 2021

Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2807%2970461-7

7 January 2021

Validation of the WHO proposals for a new classification of primary myelodysplastic syndromes: a retrospective analysis of 1600 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2807%2970461-7

7 January 2021

Myocardial iron loading by magnetic resonance imaging T2* in good prognostic myelodysplastic syndrome patients on long-term blood transfusions.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2807%2970461-7

7 January 2021

No evidence for myocardial iron overload in multitransfused patients with myelodysplastic syndrome using cardiac magnetic resonance T2 technique

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2807%2970461-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0145-2126%2807%2970461-7

1 reference

7 January 2021

10.1016/S0145-2126(07)70461-7

Identifiers

DOI

1 reference

17 August 2017

1 reference

PubMed ID

18037413